CompoAtlas

Fermented Superfood Complex with preB

Withdrawn from the US market on 1 December 2023 (according to the DSLD)

Swanson Ultra, food supplement from the US market

Label withdrawn from the US market. Fermented Superfood Complex with preB (Swanson Ultra), a food supplement au code-barres 087614027111, is described by its US market label. If sold in France, it would be subject to 3 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.

Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.

Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.

If this product were sold in France

A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.

Label composition

Brand
Swanson Ultra
Barcode
087614027111
Form
Liquid
One serving
1 teaspoon
Servings
up to 1 serving per day
Ingredient (as written, in English)CategoryPer serving
CaloriesOther10 Calorie(s)
Total CarbohydratesCarbohydrate3 Gram(s)
Dietary FiberFibre1 Gram(s)
Proprietary BlendBlend5 Gram(s)
preB
spring WaterOthernot stated
Cane Sugar, UnrefinedCarbohydratenot stated
HoneyIngredient of animal originnot stated
Orange (Citrus sinensis)Plantnot stated
Pineapple (Ananas comosus)Plantnot stated
Banana (Musa paradisiaca)Plantnot stated
ApplePlantnot stated
Papaya (Carica papaya)Plantnot stated
Guava (Psidium guajava)Plantnot stated
Melon (Cucumis melo)Plantnot stated
Brown Rice (Oryza sativa)Plantnot stated
Oat (Avena sativa)Plantnot stated
Corn (Zea mays)Plantnot stated
Barley (Hordeum vulgare)Plantnot stated
Pea (Pisum sativum)Plantnot stated
Jalo (Phaseolus vulgaris)Plantnot stated
Roxinho (Phaseolus vulgaris)Plantnot stated
Black SesamePlantnot stated
Millet (Panicum miliaceum)Plantnot stated
Plum (Prunus domestica)Plantnot stated
AdzukiPlantnot stated
Soy (Glycine max)Plantnot stated
CarrotPlantnot stated
Rye Grain (Secale cereale)Plantnot stated
Black Bean (Phaseolus vulgaris)Plantnot stated
Lentil (Lens culinaris)Plantnot stated
Avocado (Persea americana)Plantnot stated
AcerolaPlantnot stated
Lemon (Citrus limon)Plantnot stated
PearPlantnot stated
TomatoPlantnot stated
Red GrapePlantnot stated
Mango (Mangifera indica)Plantnot stated
Watermelon (Citrullus lanatus)Plantnot stated
Pumpkin (Cucurbita pepo)Plantnot stated
Sweet Potato (Ipomoea batatas)Plantnot stated
Chick PeaPlantnot stated
CarambolaPlantnot stated
CashewPlantnot stated
BrazilPlantnot stated
Kiwi (Actinidia deliciosa)Plantnot stated
Cassava (Manihot esculenta)Plantnot stated
Green Bell Pepper (Capsicum annuum)Plantnot stated
Sugar Beet (Beta vulgaris)Plantnot stated
Collard Greens (Brassica oleracea)Plantnot stated
Cabbage (Brassica oleracea)Plantnot stated
Passion FruitPlantnot stated
Chicory (Cichorium intybus)Plantnot stated
Lemongrass (Cymbopogon citratus)Plantnot stated
Lotus (Nelumbo nucifera)Plantnot stated
TurnipPlantnot stated
SeaweedOthernot stated
Mate (Ilex paraguariensis)Plantnot stated
CinnamonPlantnot stated
AnisePlantnot stated
Clove (Syzygium aromaticum)Plantnot stated
GingerPlantnot stated
Zedoary (Curcuma zedoaria)Plantnot stated
Isomalto-Oligosaccharide syrupFibre1 Gram(s)

Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.

This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Soy
    Read the warning, when it applies and the studies cited
  • Green Bell Pepper
    Read the warning, when it applies and the studies cited

    CAYENNE - CAPSICUM ANNUUM Oral

    Cautions and warnings

    Condition of application: All products.

    Keep out of the reach of children. If overdose or accidental ingestion occurs, call a poison control centre or get medical help right away (CPS 2008).

    Sources cited by Health Canada (1)
    • CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Bradley 2006; Boon and Smith 2004).

    Sources cited by Health Canada (2)
    • Boon H, Smith MJ. The Complete Natural Medicine Guide to the 50 Most Common Medicinal Herbs, 2nd edition. Toronto (ON): Robert Rose Inc; 2004.
    • Bradley PR, editor. British Herbal Compendium: A Handbook of Scientific Information on Widely Used Plant Drugs, Volume 2. Bournemouth (GB): British Herbal Medicine Association; 2006.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have stomach ulcers or inflammation (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Condition of application: Digestion; Peripheral circulation.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 27 March 2026

    CAYENNE - CAPSICUM ANNUUM/CAPSAICIN Topical

    Cautions and warnings

    Condition of application: All products.

    For external use only (US FDA 2023).

    Sources cited by Health Canada (1)
    • US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    When using this product avoid contact with the eyes and mucous membranes. If contact occurs, rinse thoroughly with water (US FDA 2023).

    Sources cited by Health Canada (1)
    • US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist, worsen, or re-occur within a few days (US FDA 2023).

    Sources cited by Health Canada (1)
    • US FDA 2023: United States Food and Drug Administration. Over-the-Counter Monograph M017: External Analgesics Drug Products for Over-the-Counter Human Use. Washington (DC): U.S. Food and Drug Administration, Department of Health and Human Services. [Accessed 2026 February 27]. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/omuf/monographs/OTC%20Monograph_M017-External%20Analgesic%20Drug%20Products%20for%20OTC%20Human%20Use%2005.02.2023.pdf

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Keep out of the reach of children. If swallowed, call a poison control centre or get medical help right away (CPS 2008).

    Sources cited by Health Canada (1)
    • CPS 2008: Repchinksy C, Welbanks L, Bhalla A, Fortin K, Jarvis B, Jovaisas B, Acharya S. Compendium of Pharmaceutical Specialties. Ottawa (ON): Canadian Pharmacists Association; 2008.

    Known adverse reactions

    Condition of application: All products.

    Stop use if headache, redness, rashes, burning discomfort and/or hypersensitivity occur (Brayfield and Cadart 2024; Zhang et al. 2008; Hoffman 2003; APhA 2002; McCleane 2000).

    Sources cited by Health Canada (5)
    • APhA 2002: Berardi RR, DeSimone EM, Newton GGD, Oszko MA, Popovich NG, Rollins CJ, Shimp LA, Tietze KJ, editors. Handbook of Nonprescription Drugs: An interactive approach to self-care. 13th edition. Washington (DC): American Pharmaceutical Association; 2002.
    • Brayfield A, Cadart C, editors. Martindale: The Complete Drug Reference. London (GB): Pharmaceutical Press; 2024. [Accessed 2024 August 14]. Available from: https://www.medicinescomplete.com/#/browse/martindale
    • Hoffman D. Medical Herbalism: The Science and Practice of Herbal Medicine. Rochester (VT): Healing Arts Press; 2003.
    • McCleane G. Topical application of doxepin hydrochloride, capsaicin and a combination of both produces analgesia in chronic human neuropathic pain: a randomized, double-blind, placebo-controlled study. British Journal of Clinical Pharmacology 2000;49:574-579. PubMed Randomised trial
    • Zhang W, Moskowitz, RW, Nuki G, Abramson S, Altman RD, Arden N, Bierma-Zeinstra S, Brandt KD, Croft P, Doherty M, Dougados M, Hochberg M, Hunter DJ, Kwoh K, Lohmander LS, Tugwell P. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis and Cartilage 2008;16:137-162. PubMed Systematic review

    Health Canada monograph dated 27 March 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).

Photograph the packaging

Brand : Swanson Ultra

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Fermented Superfood Complex with preB : étiquette retirée du marché américain (Swanson Ultra): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/87614027111-fermented-superfood-complex-with-preb-swanson-ultra, updated 1 December 2023.

List recorded in 2019. Photograph the packaging to check whether it has changed.

Enter to analyse, Shift+Enter for a new line